Three patients (two sisters and a brother) in one family are described with chronic granulomatous disease. The granulocytes of these patients did not respond with a metabolic burst to various stimuli and failed to kill catalase-positive microorganisms. The magnitude of the cytochrome b signal in the optical spectrum of the patients' granulocytes was <4% of the normal value, whereas the amount of noncovalently bound flavin in these cells was normal. The mode of inheritance of the genetic defect in this family is autosomal because the granulocytes of both parents (first cousins) and a nonaffected sister of the patients expressed 70-80% of the normal cytochrome b signal, showed low-normal or subnormal oxidative reactions during stimulation, and did not display mosaicism in the stimulated nitroblue-tetrazolium slide test. Somatic cell hybridization was performed between the monocytes from the affected boy in this family with monocytes from either a cytochrome b-negative male patient with X-linked chronic granulomatous disease or a cytochrome b-positive male patient with the classic autosomal form of this diseae. In both combinations, monocyte hybrids were observed with nitroblue tetrazolium reductase activity after stimulation with phorbol myristate acetate. This complementation of the oxidase activity required protein synthesis. Our results prove that the defect in this family is genetically distinct from that in the other two forms of chronic granulomatous disease. Moreover, our results also indicate that the expression of cytochrome b in human phagocytes is coded by at least two loci, one on the X chromosome and one on an autosome.
Introduction
Chronic granulomatous disease (CGD)' is a rare disorder in which the patients suffer from severe recurrent infections with bacteria and fungi, due to an inability of their phagocytes (neutrophils, eosinophils, and monocytes) to kill catalasepositive microorganisms (1) (2) (3) . The defective killing of these microorganisms is caused by the failure of CGD leukocytes to produce sufficient amounts of superoxide and hydrogen peroxide during phagocytosis (1) (2) (3) . The enzyme system responsible for this process is an oxidase located in the plasma membrane of the phagocytes. Although this oxidase system is usually inactive, it can be stimulated to generate O2 and H202 as a result of binding of opsonized particles or soluble stimuli to membrane receptors on the phagocyte surface (4-6).
Segal and coworkers (7) have reported that the optical spectrum of human neutrophils contains a signal of a b-type cytochrome. This signal is not detectable in the optical spectrum of the neutrophils from CGD patients with an X-linked inheritance of the disease and is present in subnormal amounts in the neutrophils of obligate heterozygotes of this type of CGD (8) . When normal neutrophils are activated under anaerobic conditions by a soluble stimulus, e.g., phorbol myristate acetate (PMA), the b-cytochrome is reduced and instantaneously reoxidized on admittance of air to the cuvette (9) . This reaction is not observed with neutrophils from patients with the (presumably) autosomal form of CGD (9) , although these cells do contain the b-cytochrome signal. These observations indicate: (a) that the b-type cytochrome is part of the respiratory burst system of human neutrophils, and (b) that the X-linked form of CGD is correlated with the cytochrome b deficiency, whereas the autosomal form of CGD is correlated with a defect in the redox reactions with cytochrome b.
It is known, however, that the heterogeneity of CGD is more extensive than just the X-linked, cytochrome-b-negative and the autosomal, cytochrome b-positive forms. A family with an X-linked, cytochrome b-positive CGD patient has been reported (10) . Moreover, "variant" forms of CGD, both X-linked and autosomal, have also been described in which the patients' phagocytes respond to some but not to all stimuli of the oxidase system (3) . This heterogeneity of CGD may reflect the complexity of the oxidase system, in that the disease may become manifest not only when components of this enzyme system are missing or structurally altered but also when defects occur in the activation mechanism. The distinction between these different forms of CGD can be very difficult because heterozygotes have only been found in the X-linked forms of the disease, extreme lyonization may obscure the classification, and the families are often small and genetically noninformative.
Recently, we have described a method to solve this classification problem (11) . When monocytes from an X-linked, cytochrome b-negative CGD patient are fused with monocytes from an autosomal, cytochrome b-positive CGD patient, the somatic cell hybrids express nitroblue tetrazolium (NBT) reductase activity in the presence of PMA, indicating that the oxidase activity is restored in the fused monocytes. This proves that these two forms of CGD represent genetically distinct abnormalities. We now present evidence for a third form of CGD detected with this fusion technique.
Methods
Patients. We have studied the phagocytes of six members of a Turkish family (Fig. 1) , in which the parents are first cousins. The clinical details and some of the laboratory findings have been described previously (12 Histological studies in 112, 113, and II4 showed only in 113 some granuloma formation in several organs. In all three of these children pigmented histiocytes were found, probably as an aspecific sign of chronic infection, inflammation, or both. Parameters of humoral immunity showed high serum levels of IgG, IgA, IgE, and total complement in 112, II3, and 114. High amounts of IgE were also found in the serum of 115. Isohemagglutinin and viral antibody titers were normal in all subjects, as was the opsonizing capacity of the sera for Staphylococcus aureus. Lymhocyte functions were also normal (percentage of T and B cells, induration after intradermal injection of varidase or candida extract, proliferation in vitro after stimulation with phytohemagglutinin or allogeneic lymphocytes).
Chemotaxis of neutrophils in vivo and in vitro and phagocytosis of S. aureus and Lactobaccilus acidophilus in vitro in the presence of normal serum were normal. However, the neutrophils of the three affected children (II2, II3, and 114) had no killing capacity for S. aureus or Candida albicans in vitro, whereas the youngest child (II5) and both parents had neutrophils with normal activity. The bactericidal activity against L. acidophilus was normal in the two patients tested (112 and 113). The oxidative metabolism of the patients' neutrophils was also clearly abnormal. During phagocytosis of serum-treated zymosan (STZ), oxygen consumption was not increased and hydrogen peroxide formation was not detectable when the neutrophils of the three affected children were tested, but were low-normal with the neutrophils of the other family members. Hydrogen peroxide production by monocytes (only tested in II3) was also undetectable. Figure 1 . Pedigree of the family described in this article.
NBT in the nylon column dye test was strongly decreased in the three affected siblings, but low-normal in the other family members. The activities of glucose-6-phosphate dehydrogenase, 6-phosphogluconate dehydrogenase, glutathione peroxidase, glutathione reductase, and myeloperoxidase were normal in the neutrophil lysates of all family members.
Materials. Percoll, Sepharose 4B, and Sulphopropyl Sephadex C-SO were obtained from Pharmacia Fine Chemicals, Uppsala, Sweden. Lucigenin (10,10'-dimethyl-9,9'-biacridinium dinitrate; Sigma Chemical Co., St. Louis, MO), PMA (Consolidated Midland Corp., Katonah, NY), calcium ionophore A23187 (Calbiochem-Behring Corp., San Diego, CA), formyl-methionyl-leucyl-phenylalanine (FMLP; Vega Biochemicals, Tucson, AZ), cytochalasin B (ICI Research Laboratories, Alderley Park, Cheshire, United Kingdom) and NBT (Sigma Chemical Co.) were dissolved in dimethyl sulfoxide and stored at -70'C. STZ was prepared as described before (13) . Nuclear fast red (Merck & Co., Darmstadt, Federal Republic of Germany) was dissolved to 1 mg/ml in 5% (weight/volume) A12(SO4)3 solution of 70'C and filtered before use. Polyethylene glycol (mol wt, 4000) was obtained from Merck & Co.
Cell separation. All cell separations were performed under sterile conditions. Granulocytes were purified from citrated blood by centrifugation over Percoll with 0.5% (weight/volume) human albumin and 15 mM sodium citrate (specific gravity, 1.077 g/cm3, 290 mosmol, pH 7.4), followed by NH4CI lysis of the erythrocytes in the pellet at 4°C (three times), essentially as described before (14) . Monocytes were purified from the interface of the Percoll separation by elutriation centrifugation (15). The cells were suspended in incubation medium (138 mM NaCl, 2.9 mM KCl, 8.1 mM Na2HPO4, 1.5 mM KH2PO4, 0.6 mM CaC12, 1.0 mM MgCl2, 5.5 mM glucose, and 0.5% [weight/ volume] human albumin). The resulting cell suspensions were 90-95% pure.
Chemiluminescence assay. Mini vials (Packard Instrument Co., Downers Grove, IL) were filled with 1.95 ml of incubation medium, containing lucigenin (320 AM) and one of the following stimuli: STZ (1 mg/ml), PMA (160 nM), A23187 (10 AM), or FMLP (2 MM) with cytochalasin B (10 ug/ml). The vials were placed in polyethylene counting vials in a scintillation spectrometer with a controlled temperature of 37°C (Packard Tri-carb 3310, Packard Instrument Co.). The reaction was started by the addition of 5 X 104 granulocytes in 0.05 ml of incubation medium. Each vial was counted continuously for 6 min in the out-of-coincidence mode of the apparatus.
NBT slide test. NBT (50 mg/ml in dimethyl sulfoxide) was diluted ten times with phosphate-buffered saline (PBS; 140 mM NaCl, 9.2 mM Na2HPO4, 1.3 mM NaH2PO4; pH 7.4) and pressed through a filter with pores of 0.45 ,um. This solution was used only on the day of preparation. Granulocytes or monocytes (6 X 101 cells in 0.9 ml of incubation medium) were mixed with 0.1 ml of the NBT solution and incubated for 30 min at 37°C in the presence or absence of PMA (160 nM). Next, one sample was fixed in suspension for 5-10 min with paraformaldehyde (final concentration, 1%) and -100,000 cells were spun on a glass slide with a Shandon Elliot Cytospin centrifuge (10 min, 600 rpm, room temperature). The slide was dried in air for about 5 min and stained for 10 min with nuclear fast red (0.1%, weight/ volume, freshly filtered). Another cell sample (-4 X 104 cells) was first spun onto a glass slide, dried in air for at least 5 min, and stained with May-Grunwald solution (undiluted) for 5 min, followed by Giemsa solution (diluted 20 times in 10 mM phosphate buffer, pH 7) for 30 min. Both slide preparations were rinsed with tap water, airdried, and embedded in malinol for microscopic examination. From each donor, 1,000 cells were scored as NBT-positive or NBT-negative in the nuclear fast red-stained preparations. Further were centrifuged (800 g, 10 min, 4°C). The pellet was lysed by freezing and addition of 1 ml of distilled water to the frozen pellet. The lysed cytoplasts were centrifuged again (40 min, 160,000 g, 4°C). The membrane pellet and the supernate (cytoplasm) were extracted each with 1.0 ml of 5% (weight/volume) trichloroacetic acid. Denatured protein was spun down (10 min, 8,000 g, 4°C). To ensure complete removal of acid-extractable flavins, the pellets were treated with 1.0 ml of ice-cold 1% (weight/volume) trichloroacetic acid and centrifuged once more (10 min, 8,000 g, 4°C). The supernates from the membrane extractions were neutralized immediately and combined, as were the supernates from the cytoplasm extractions. The flavins were analyzed within 30 min (to limit hydrolysis of flavin adenine dinucleotide [FAD]) at pH 2.6 and 7.7, according to Faeder and Siegel (19) . Flavin mononucleotide and FAD (Sigma Chemical Co.) were used as internal and external standards. More than 90% of the extracted flavin proved to be FAD (20) . The extraction of noncovalently-bound flavins from whole granulocyte homogenates was essentially as described for the cytoplasts. In the optical spectra of the granulocytes from the three affected children, the cytochrome b signal was hardly demon- (Fig. 3) . Table I shows that this represents 2-4% of the normal cytochrome b content. Subnormal amounts of cytochrome b were found in the granulocytes from the nonaffected child and the parents. The shape ofthe cytochrome b spectrum from the parents (not shown) and the unaffected child 115 (Fig. 3) was normal. The amount of noncovalently bound flavins was determined in the membranes and cytoplasm of granulocyte cytoplasts. Table I shows that both values were normal in all family members. Furthermore, the amount of nonconvalently bound flavins was also determined in the homogenate of whole granulocytes from patient 112. This value, too, was normal; patient II2, 4.4 pmol/106 granulocytes; 8 controls, 4 .6±0.55 pmol/106 granulocytes (mean±SD).
In the PMA-stimulated NBT slide test, a very low proportion of NBT-positive cells was detected in the preparations from patients 113 and 14, whereas no NBT-positive cells were observed in the preparation from patient 112 ( Table I ). All granulocytes of the other three family members showed a 100% positive NBT test. In contrast, obligate carriers of Xlinked CGD showed a mosaic of strongly positive and completely negative granulocytes. (A and B) with the X-linked, cytochrome-b-negative form of CGD were fused, the resulting hybrids were all NBT-negative when tested with PMA. These hybrids remained unreactive to PMA when tested after 15 or 40 h of culture. Identical results were obtained with the monocytes from two unrelated, male patients (C and D) with the cytochrome-b-positive, autosomal recessive form of CGD. However, fusion of monocytes from patient A with patient C led to 32% PMA-reactive hybrids immediately after fusion. This percentage did not change significantly after 15 or 40 h of maintenance culture. Theoretically, the maximal percentage of NBT-positive hybrids is 50%
because fusion between cells from the same donor occurs with the same probability as fusion between cells from different donors. Essentially, the same results were obtained when the monocytes of patient B were fused with those of patient D, and with the combination A X D (Table II) . Nonfused monocytes of these four patients always remained PMA-unreactive in culture, in contrast with monocytes from healthy individuals which always remained NBT-positive. Fusion of monocytes from a single patient gave rise to homologous hybrids; with all four patients, these hybrids remained PMA-unreactive after culture. Homologous hybrids of normal monocytes remained PMA-reactive. These results indicate that patients A and B belong to one complementation group, whereas patients C and D belong to another complementation group. We then purified the monocytes of patient 113 (a boy) and fused these cells with the monocytes of patient B or patient D (Table II) . The combination II3 X B did not show PMAreactive hybrids immediately after fusion. However, after 15 h In another experiment, the purified monocytes of patient 114 (a girl) were fused with those from a third male CGD patient with the X-linked, cytochrome-b-negative form of the disease. Again, PMA-reactive hybrids appeared in the course of 2 d of culture. However, when cycloheximide (1 gg/ml) was added directly after fusion, the hybrids remained PMA-unreactive, whereas addition of cycloheximide had no effect up to 40 h on the percentage of positive hybrids in the combination A X C (11). Hybrids of monocytes from patients II3 X II4 also remained PMA-unreactive.
Discussion
The patients described in this paper must be regarded as CGD patients because their phagocytes are functionally indistinguishable from the phagocytes of patients with CGD. However, the clinical histories of the patients are different from those of most other CGD patients, and more reminiscent of, although not identical with (12) , those of the patients with lipochrome histiocytosis described by Ford et al. (21) . Metabolically, the phagocytes of the patients here described are slightly different from those of classic CGD patients (very low activity in the NBT slide test with PMA and in the chemiluminescence assay with FMLP as well as a very low cytochrome b content). We have now found proof that the patients described in the present report belong to a separate type of CGD, with a different genetic mutation from either X-linked, cytochrome-b-negative or autosomal recessive, cytochrome-b-positive CGD.
There are strong indications that the defect in the presently described family is inherited in an autosomal way. Firstly, the amount of cytochrome b in the granulocytes was diminished in the nonaffected family members and hardly detectable in the patients. Secondly, low-normal or subnormal values were found with the granulocytes of the parents and their nonaffected daughter II5 in the oxygen consumption, hydrogen peroxide generation, NBT reduction (nylon column), and chemiluminescence assays. And finally, in the NBT slide test, no mosaicism was found in the granulocytes of the nonaffected girl or the parents.
Recently, a number of reports have described a diminished amount of flavins in CGD cells, both with and without cytochrome b deficiency (22) (23) (24) . In the family here described, we found that the noncovalently bound flavin (mostly FAD) was present in normal amounts in the membranes and in the cytoplasm of granulocyte cytoplasts. Because cytoplasts generate similar amounts of superoxide and hydrogen peroxide per unit surface area upon stimulation as do intact granulocytes (18), those flavoproteins that are associated with the oxidase activity must be present in cytoplasts as well as in intact cells. Therefore, the fact that we found normal amounts of noncovalently bound flavins in the granulocyte cytoplasts from this family indicates that oxidase-associated flavoproteins were not deficient in this family. Moreover, the amount of nonconvalently bound flavins in the homogenate from whole granulocytes in patient 112 was also normal.
Because most CGD patients recorded at present either suffer from an X-linked, cytochrome-b-negative form of the disease or from a (presumably) autosomal recessive, cytochrome-b-positive form, the family here described (autosomal, cytochrome-b-negative) might belong to a third type of CGD. This notion was tested by monocyte hybridization. Indeed, as described before (1 1), we found complementation between the first two types of CGD but not within these groups, which proves that these two types are due to mutations at different genetic loci. We also found that the monocytes from the patients in the family described here gave rise to PMA-reactive hybrids with the monocytes from either of the two other types of CGD. This proves that the metabolic defect in this family is genetically different from that of both X-linked, cytochromeb-negative and autosomal, cytochrome-b-positive CGD.
The granulocytes from patient II3, as well as the homologous monocyte hybrids, showed a low percentage of PMA-reactive cells, in contrast to the cells or hybrids from other CGD patients. This difference might be caused by the very small amount of cytochrome b still present in the cells of patient 113.
The lag-time observed in the appearance of PMA-reactive hybrids when the monocytes of 113 or II4 were fused with those of other CGD patients suggests that protein synthesis is required for the full expression of the NBT reductase activity in these hybrids. Indeed, cycloheximide prevented these hybrids from acquiring the ability to reduce NBT. In contrast, we found previously that protein synthesis is not required for the expression of the NBT reductase in hybrids of monocytes from X-linked, cytochrome-b-negative CGD patients with monocytes from autosomal, cytochrome-b-positive CGD patients (11) . In this latter combination, it appears that the components of the oxidase and of the activation mechanism for this system are donated directly by the fusing cells, and perhaps combine in the plasma membrane of the hybrids to form an active complex. The present results show that granulocytes or (cryopreserved) cytoplasts (25) should not be used for complementation studies because these cells lack protein synthesis.
Because cytochrome-b-negative phagocytes are found both in X-linked CGD and in the autosomal form of CGD described here, the expression of the b-heme protein is coded by at least two loci, one on the X-chromosome and one on an autosome. It may seem strange that the expression of one protein (cytochrome b) is coded by two different genetic loci. One must realize, however, that the expression of cytochrome b is measured spectrally. Absence of the b-heme optical signal may be caused by a number of different defects, e.g., a defect in the locus that codes for the protein of cytochrome b, a defect in the locus that codes for an enzyme needed for the heme incorporation into cytochrome b, a defect in the locus for an anchoring protein of cytochrome b, etc. It is conceivable, therefore, that protein synthesis is needed in the somatic cell hybrids between the two forms of cytochrome-b-negative CGD for the expression of NBT-reductase activity. We expect that this protein synthesis leads to expression of cytochrome b in these hybrids. Unfortunately, however, the fusion efficiency is so low that it is impossible to obtain enough hybrids to measure the b-heme signal.
It is clear that the complete unravelling of the molecular biology of the NADPH oxidase system of phagocytes requires much more work. It is also clear, however, that study of CGD patients, especially those with unusual abnormalities, yields important information about the composition of the oxidase system. The technique of monocyte hybridization can be of great value in these investigations.
